What is/are NOT the features of the BioPharma SHAKTI mission proposed in the Union Budget 2026-27?

I. The initiative aims to strengthen India's biopharmaceutical manufacturing sector with an outlay of about Rs. 10,000 crore over five years.

II. It envisages strengthening India's ecosystem for the production of biologics and biosimilars and capturing 5% of the global biopharmaceutical market share.

Choose the correct option: